NCT03957733 2022-04-06Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.King Abdullah Medical CityPhase 2/3 Unknown338 enrolled
NCT03939962 2022-01-26Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional AdenocarcinomaHenan Cancer HospitalPhase 2 Unknown60 enrolled
NCT04155671 2019-11-07POF Versus FOLFOX Plus IP Paclitaxel in AGCFujian Cancer HospitalPhase 2 Unknown260 enrolled